Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTc with Artesunate + SP for Malaria Prevention in Senegal
NCT00132561Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2002
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of artesunate, sulfadoxine and pyrimethamine in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Incidence of clinical attacks of malaria. Started Jun 2002; status: completed.
02
Drugs
artesunatesulfadoxinepyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00132561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132561.